Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2019

09.05.2018 | Original Research

Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015

verfasst von: Rahmatollah Moradzadeh, Parvaneh Golmohammadi, Bahman Ghaitasi, Haidar Nadrian, Athareh Najafi

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Even though Kurdistan, the western province of Iran, has a cancer surveillance system, a detailed analysis of incidence rate has not been yet performed. We describe Age Standardized Incidence Rates (ASRs) for esophageal cancer (EC) in Kurdistan Province of Iran in 2001–2015.

Methods

Incidence cases of EC were obtained from a population-based cancer registry. We obtained ASRs and 95% confidence intervals (CI) per 100,000 populations for each calendar year group.

Results

Between 2001 and 2015, 1362 incidence cases with EC were reported to the cancer registry. Annual ASRs in 2006–2010 were more than the other years in both men and women, respectively. Most ASRs were reported among women in Divandarreh (18.95, 95% CI 14.76, 23.92), Saqez (12.75, 95% CI 10.73, 15.01), Sanandaj (8.84, 95% CI 7.64, 10.17), and Qorveh (8.19, 95% CI 6.54, 10.12), and among men in Divandarreh (19.38, 95% CI 15.38, 24.06), Saqez (13.64, 95% CI 11.49, 16.05), Sanandaj (8.70, 95% CI 7.56, 9.96), and Marivan (7.93, 95% CI 6.26, 9.88).

Conclusions

It was concluded that EC in Divandarreh, Saqez, and Sanandaj has the highest ASRs, and these areas are considered as high-risk areas for this disease in the Iranian province of Kurdistan. Therefore, to understand the reasons of these problems, a considerable work is needed.
Literatur
2.
Zurück zum Zitat Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://doi.org/10.1001/jamaoncol.2016.5688.CrossRef Global Burden of Disease Cancer C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. https://​doi.​org/​10.​1001/​jamaoncol.​2016.​5688.CrossRef
6.
Zurück zum Zitat Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost A. Opium use as a risk factor for upper gastro-intestinal cancers: a population-based case control study in Iran. Arch Iran Med. 2014;17(1):2–6.PubMed Naghibzadeh Tahami A, Khanjani N, Yazdi Feyzabadi V, Varzandeh M, Haghdoost A. Opium use as a risk factor for upper gastro-intestinal cancers: a population-based case control study in Iran. Arch Iran Med. 2014;17(1):2–6.PubMed
7.
Zurück zum Zitat Ghasemi-Kebria F, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.PubMed Ghasemi-Kebria F, Semnani S, Shakeri R, Khoshnia M, Naeimi-Tabiei M, Merat S, et al. Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. Arch Iran Med. 2013;16(6):320–3.PubMed
8.
Zurück zum Zitat Haghdoost A, Hosseini H, Chamani G, Zarei M, Rad M, Hashemipoor M, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–70.PubMed Haghdoost A, Hosseini H, Chamani G, Zarei M, Rad M, Hashemipoor M, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364–70.PubMed
13.
Zurück zum Zitat Bray F, Ferlay J. Age standardization. In: Forman D, Bray F, Brewster DH, et al., editors. Cancer Incidence in Five Continents, vol X. Lyon: IARC Scientific Publication No. 164, International Agency for Research on Cancer; 2014. Bray F, Ferlay J. Age standardization. In: Forman D, Bray F, Brewster DH, et al., editors. Cancer Incidence in Five Continents, vol X. Lyon: IARC Scientific Publication No. 164, International Agency for Research on Cancer; 2014.
14.
Zurück zum Zitat Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701.CrossRef Consonni D, Coviello E, Buzzoni C, Mensi C. A command to calculate age-standardized rates with efficient interval estimation. Stata J. 2012;12(4):688–701.CrossRef
18.
Zurück zum Zitat Mohagheghi M-A, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran Metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 12(1):15–23. Mohagheghi M-A, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran Metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 12(1):15–23.
22.
Zurück zum Zitat Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Br Med J. 2009;338 https://doi.org/10.1136/bmj.b929. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ: Br Med J. 2009;338 https://​doi.​org/​10.​1136/​bmj.​b929.
23.
Zurück zum Zitat Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M. Opium: an emerging riskfactor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.CrossRefPubMed Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M. Opium: an emerging riskfactor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.CrossRefPubMed
24.
Zurück zum Zitat Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.PubMed Fallahzadeh MA, Salehi A, Naghshvarian M, Fallahzadeh MH, Poustchi H, Sepanlou SG, et al. Epidemiologic study of opium use in pars cohort study: a study of 9000 adults in a rural southern area of Iran. Arch Iran Med. 2017;20(4):205–10.PubMed
29.
Zurück zum Zitat Moradzadeh R, Mansournia MA, Baghfalaki T, Ghiasvand R, Noori-Daloii MR, Holakouie-Naieni K. Misclassification adjustment of family history of breast cancer in a case-control study: a Bayesian approach. Asian Pac J Cancer Prev. 2015;16:8221–6.CrossRefPubMed Moradzadeh R, Mansournia MA, Baghfalaki T, Ghiasvand R, Noori-Daloii MR, Holakouie-Naieni K. Misclassification adjustment of family history of breast cancer in a case-control study: a Bayesian approach. Asian Pac J Cancer Prev. 2015;16:8221–6.CrossRefPubMed
Metadaten
Titel
Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001–2015
verfasst von
Rahmatollah Moradzadeh
Parvaneh Golmohammadi
Bahman Ghaitasi
Haidar Nadrian
Athareh Najafi
Publikationsdatum
09.05.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2019
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0114-3

Weitere Artikel der Ausgabe 3/2019

Journal of Gastrointestinal Cancer 3/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.